Cargando…
The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia
The 2016 WHO diagnostic criteria for chronic myelomonocytic leukemia (CMML) require both absolute and relative monocytosis (≥1×10(9)/L and ≥10% of white blood cell counts) in peripheral blood. Moreover, myeloproliferative neoplasm (MPN) features in bone marrow and/or MPN-associated mutations tend to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973924/ https://www.ncbi.nlm.nih.gov/pubmed/29797820 http://dx.doi.org/10.3343/alm.2018.38.5.481 |
_version_ | 1783326708471955456 |
---|---|
author | Moon, Yeonsook Kim, Mi Hyang Kim, Hye Ryoun Ahn, Jeong-Yeal Huh, Jungwon Huh, Ji Young Han, Jae Ho Park, Joon Seong Cho, Sung Ran |
author_facet | Moon, Yeonsook Kim, Mi Hyang Kim, Hye Ryoun Ahn, Jeong-Yeal Huh, Jungwon Huh, Ji Young Han, Jae Ho Park, Joon Seong Cho, Sung Ran |
author_sort | Moon, Yeonsook |
collection | PubMed |
description | The 2016 WHO diagnostic criteria for chronic myelomonocytic leukemia (CMML) require both absolute and relative monocytosis (≥1×10(9)/L and ≥10% of white blood cell counts) in peripheral blood. Moreover, myeloproliferative neoplasm (MPN) features in bone marrow and/or MPN-associated mutations tend to support MPN with monocytosis rather than CMML. We assessed the impact of the 2016 WHO criteria on CMML diagnosis, compared with the 2008 WHO criteria, through a retrospective review of the medical records of 38 CMML patients diagnosed according to the 2008 WHO classification. Application of the 2016 WHO criteria resulted in the exclusion of three (8%) patients who did not fulfill the relative monocytosis criterion and eight (21%) patients with an MPN-associated mutation. These 11 patients formed the 2016 WHO others group; the remaining 27 formed the 2016 WHO CMML group. The significant difference in the platelet count and monocyte percentage between the two groups indicated that the 2016 WHO criteria lead to a more homogenous and improved definition of CMML compared with the 2008 WHO criteria, which may have led to over-diagnosis of CMML. More widespread use of molecular tests and more sophisticated clinical and morphological evaluations are necessary to diagnose CMML accurately. |
format | Online Article Text |
id | pubmed-5973924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Society for Laboratory Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-59739242018-09-01 The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia Moon, Yeonsook Kim, Mi Hyang Kim, Hye Ryoun Ahn, Jeong-Yeal Huh, Jungwon Huh, Ji Young Han, Jae Ho Park, Joon Seong Cho, Sung Ran Ann Lab Med Brief Communication The 2016 WHO diagnostic criteria for chronic myelomonocytic leukemia (CMML) require both absolute and relative monocytosis (≥1×10(9)/L and ≥10% of white blood cell counts) in peripheral blood. Moreover, myeloproliferative neoplasm (MPN) features in bone marrow and/or MPN-associated mutations tend to support MPN with monocytosis rather than CMML. We assessed the impact of the 2016 WHO criteria on CMML diagnosis, compared with the 2008 WHO criteria, through a retrospective review of the medical records of 38 CMML patients diagnosed according to the 2008 WHO classification. Application of the 2016 WHO criteria resulted in the exclusion of three (8%) patients who did not fulfill the relative monocytosis criterion and eight (21%) patients with an MPN-associated mutation. These 11 patients formed the 2016 WHO others group; the remaining 27 formed the 2016 WHO CMML group. The significant difference in the platelet count and monocyte percentage between the two groups indicated that the 2016 WHO criteria lead to a more homogenous and improved definition of CMML compared with the 2008 WHO criteria, which may have led to over-diagnosis of CMML. More widespread use of molecular tests and more sophisticated clinical and morphological evaluations are necessary to diagnose CMML accurately. The Korean Society for Laboratory Medicine 2018-09 2018-05-23 /pmc/articles/PMC5973924/ /pubmed/29797820 http://dx.doi.org/10.3343/alm.2018.38.5.481 Text en © The Korean Society for Laboratory Medicine http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Moon, Yeonsook Kim, Mi Hyang Kim, Hye Ryoun Ahn, Jeong-Yeal Huh, Jungwon Huh, Ji Young Han, Jae Ho Park, Joon Seong Cho, Sung Ran The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia |
title | The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia |
title_full | The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia |
title_fullStr | The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia |
title_full_unstemmed | The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia |
title_short | The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia |
title_sort | 2016 who versus 2008 who criteria for the diagnosis of chronic myelomonocytic leukemia |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973924/ https://www.ncbi.nlm.nih.gov/pubmed/29797820 http://dx.doi.org/10.3343/alm.2018.38.5.481 |
work_keys_str_mv | AT moonyeonsook the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT kimmihyang the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT kimhyeryoun the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT ahnjeongyeal the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT huhjungwon the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT huhjiyoung the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT hanjaeho the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT parkjoonseong the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT chosungran the2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT moonyeonsook 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT kimmihyang 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT kimhyeryoun 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT ahnjeongyeal 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT huhjungwon 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT huhjiyoung 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT hanjaeho 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT parkjoonseong 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia AT chosungran 2016whoversus2008whocriteriaforthediagnosisofchronicmyelomonocyticleukemia |